Recombinant TdT antibody
Quick Overview for Recombinant TdT antibody (ABIN7477595)
Target
See all TdT (DNTT) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC 1:75-1:150
-
Comment
-
Positive Control: Thymus: At least a moderate nuclear immunostaining should be seen in virtually all cortical lymphocytes of the normal thymus.
Negative Control: Thymus: The vast majority of the medullary lymphocytes of the normal thymus should be negative. , Tonsil: The vast majority of lymphoid cells and all epithelial cells should be negative.
-
Protocol
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:100 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Alternative Name
- TdT
-
Background
- Deoxynucleotidyltransferase terminal, DNTT, Nucleosidetriphosphate DNA Deoxynucleotidylexotransferase, TDT, Terminal addition enzyme, Terminal deoxynucleotidyltransferase, Terminal deoxyribonucleotidyltransferase,TdT antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- P04053
-
Pathways
- DNA Damage Repair
Target
-